Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v2-FR
Language English French
Date Updated 2024-10-01 2024-03-22
Drug Identification Number 00839191 00839191
Brand name SANDOSTATIN SANDOSTATIN
Common or Proper name SANDOSTATIN 50UG 1X5 AMPS SANDOSTATIN 50UG 1X5 AMPS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients OCTREOTIDE OCTREOTIDE
Strength(s) 50MCG 50MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1 X 5 1 X 5
ATC code H01CB H01CB
ATC description HYPOTHALAMIC HORMONES HYPOTHALAMIC HORMONES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-08-30 2024-08-30
Actual start date 2024-06-17
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments